A Randomised Clinical Trial of a Digital Self-management Package for People With Interstitial Lung Disease

NARECRUITING

The goal of this clinical trial is to compare REBUILD-SM (a purpose-built smartphone app and self-management package) with standard care in people with interstitial lung disease (ILD). The main question it aims to answer is: • Does REBUILD-SM improve health-related quality of life, symptoms, anxiety, self-efficacy and physical activity for people with ILD? Participants in the intervention group will work through the self-management package with support from a healthcare professional via phone or Zoom. They will also enter deidentified health data into the RE-BUILD smartphone app to track their progress over time.

Participants in the control group will use a reduced functionality version of the smartphone app only. Researchers will compare both groups to see if there is any difference in health-related quality of life, symptoms, anxiety, self-efficacy and level of physical activity.

Study details:

This study compares REBUILD-SM with standard care in people with ILD. REBUILD-SM comprises a purpose-built smartphone app that allows subjects to enter and track health data over time and an integrated self-management package. Participants will enter their respiratory diagnosis, medications and side effects, weight, lung function test results, oxygen saturation level and supplemental oxygen usage into the smartphone app.

They will also complete questionnaires at specific timepoints using the app. Participants will input most of this data at the beginning of the trial and update it when it changes, for example, after obtaining a new lung function result, starting a new medication, or getting a new side effect from an existing medication. Entering data into the app is expected to take around 30 minutes at the start of the trial, and about 20 minutes at 12, 26 and 52 weeks when completing the questionnaires.

Updating data is expected to take about 5-10 minutes and will only happen when there is a change, for example, once per week, although it may not be this frequent. The app will not provide any recommendations on the health data participants enter - it is simply for recording purposes. To ensure data collection is as complete as possible, electronic reminders will be sent to participants when questionnaires are not completed at the specified timepoints and will alert the study team if the participant fails to complete the questionnaires after the reminder.

This will prompt a phone call from a member of the study team to encourage the participant to complete the endpoints. App analytics will be used in the data analysis phase (after the trial is over) to understand how participants have engaged with the app. Participants in the intervention group will be asked to log into and use the self-management website or view the content via the REBUILD app with support from the study team.

The self-management content includes 13 modules and has been designed in collaboration with people with ILD to help increase their ability to self-manage their chronic disease. During the intervention period, participants will receive four phone calls from a health professional involved in the management of people with ILD to help them set health-related goals and identify appropriate modules from the website to help achieve these goals. These four phone calls are expected to take about 15-30 minutes each.

Each module provides information regarding the topic and provides access to relevant websites, fact sheets, booklets, videos and webinars as well as other external resources. Participants will have direct access to these external resources from within the package through hyperlinks embedded in the title of each resource. Participants are expected to work through their selected modules at their own pace - there is no specific amount of time they are required to allocate to the intervention, and they can utilize as many or as few of the resources as they like.

Eligibility criteria

Researchers look for people who fit a certain description, called eligibility criteria. See if you qualify.

Inclusion criteria

  1. Diagnosis of fibrotic ILD
  2. In possession of a smartphone/tablet and an email address
  3. Able to understand written and spoken English
  4. Adequate digital literacy to complete requirements of trial
  5. On stable ILD treatment for 30 days prior to enrolment

Exclusion criteria

  1. Not in possession of a smartphone/tablet
  2. Insufficient digital literacy to complete requirements of trial
  3. Unable to communicate in written/spoken English
  4. Not on stable ILD treatment for 30 days prior to enrolment
  5. Acute exacerbation within 30 days prior to enrolment
  6. Participating in pulmonary rehab at enrolment or during 12-week intervention period
  7. Unable to provide informed consent

Eligibility

Age eligible for study : NA

Healthy volunteers accepted : No

Gender eligible for study: ALL

Things to know

Study dates

Study start:

Primary completion:

Study completion finish:

study type

Study type

SUPPORTIVE_CARE

phase

Phase

    NA

trial

Study ID

NCT06122233

Intervention or treatment

BEHAVIORAL: Pulmonary Fibrosis self-management package and smartphone application

Conditions

  • Lung Diseases, Interstitial
  • Pulmonary Fibrosis
  • Condition: Lung Diseases, Interstitial, Pulmonary Fibrosis

  • BEHAVIORAL: Pulmonary Fibrosis self-management package and smartphone application

  • Sydney, New South Wales, Australia and more

  • Sponsor: University of Sydney

You may be eligible to participate in this trial based on your search. Check eligibility by answering some questions.

Are you running this trial?

If you're a clinic or sponsor, you can claim this study

Research sites nearby

Closest Location:

Royal Prince Alfred Hospital

Select from list below to view details:

  • Royal Prince Alfred Hospital

    Sydney, New South Wales, Australia

  • The Prince Charles Hospital

    Brisbane, Queensland, Australia

  • Alfred Hospital

    Melbourne, Victoria, Australia

  • Austin Health

    Melbourne, Victoria, Australia

Loading map...

Who is running the clinical trial?

UoS

University of Sydney

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Participant Group/ArmIntervention/Treatment
EXPERIMENTAL: REBUILD-SM Group
  • Participants randomised to the intervention will receive the self-management package, including the REBUILD app. Structured self-management support via telephone or Zoom call will be provided 4 times during the 12-week intervention period.
Behavioral: Pulmonary Fibrosis self-management package and smartphone application
    NO_INTERVENTION: Standard Care Group
    • In the control arm, participants will receive standard care and a reduced capability version of the REBUILD app to be used for data-capture only. They will also receive phone/Zoom calls at the same frequency during the 12-week intervention period, but no health advice will be given. After 26 weeks, participants in this group will receive access to the fully functional REBUILD app, however they will not receive the self-management content or the support phone calls provided to the intervention group.

      What is the study measuring?

      Primary Outcome

      MeasureDescriptionTime Frame
      Change in King's Brief Interstitial Lung Disease (K-BILD) questionnaire scoreScore range 0 - 100; higher score corresponding to better outcome.Baseline and 12 weeks post-randomisation

      Secondary Outcome

      MeasureDescriptionTime Frame
      Change in K-BILD scoreAs above26 and 52 weeks post-randomisation
      Change in European Quality of Life 5-Dimensions 5-Level (EQ-5D-5L) questionnaire scoreScore range 11111 - 55555; 0-100; higher score indicating worse outcomeBaseline, 12, 26 and 52 weeks post-randomisation
      Change in General Self-Efficacy Scale scoreScore range 10 - 40; higher score indicating low level of perceived self-efficacyBaseline, 12, 26, and 52 weeks post-randomisation
      Change in Dyspnoea-12 scoreScore range 0-36; higher score corresponding to greater level of dyspnoeaBaseline, 12, 26 and 52 weeks post-randomisation
      Change in Hospital Anxiety and Depression Scale scoreScore range 0-21 (for anxiety and depression); higher scores corresponding to severe anxiety and/or depressionBaseline, 12, 26 and 52 weeks post-randomisation
      Change in physical activity levelsChange in steps per day and change in time spent in the four intensity categories (inactive, low, medium and high activity) will be measured using a physical activity monitorBaseline, 12 and 52 weeks post-randomisation
      Uptake/ changes to ILD treatmentsIncludes changes to medications, commencement or change in supplemental oxygen use, participation in pulmonary rehabBaseline, 12, 26 and 52 weeks post-randomisation
      Change in mHealth App Usability questionnaire (MAUQ) scoreScore range 18-126; higher score indicating greater satisfaction with the REBUILD app12, 26 and 52 weeks post-randomisation
      Change in e-Health Literacy (eHEALS) questionnaire scoreScore range 8-40; higher score indicating higher degree of perceived e-health literacyBaseline,12 and 52 weeks post-randomisation
      Health Care Climate questionnaireScore range 6-42; higher score indicating greater satisfaction with treating team12 weeks post-randomisation
      Are you running this trial?If you're a clinic or sponsor, you can claim this study.

      References

      Clinical Trials Gov: A Randomised Clinical Trial of a Digital Self-management Package for People With Interstitial Lung Disease

      Other trials to consider

      Loading suggested trials...

      Top searched conditions